ARCHIVES

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

This article is from The Cancer Letter archive.

Vol. 31 No. 44 | December 2, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Approvals: Cobas HPV Test Approved For Primary Cervical Screening

April 25, 2014

NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation

March 13, 2009

ACS names new officers.

December 5, 2003

In Brief: Wyngaarden Delays Gene Transfer Study, Seeks all Information; Rosenberg Wins Griffuel Prize

October 28, 1988

Consensus Conference On Receptors Planned

June 22, 1979

Computer Interpretation Software Does Not Improve Detection

August 26, 2011